Dr Susan Harden works as a Consultant Radiation Oncologist at the Peter MacCallum Cancer Centre, and is a senior research fellow for the Cancer Registries Research Programme at Monash University.
She qualified in medicine from Oxford University and completed her specialist training in Cambridge, UK, where she worked as a consultant from 2006-2019. She was awarded a Doctorate in Medicine for her 2 years of translational research undertaken at the Johns Hopkins University Hospital, Baltimore, USA, focusing on the low level molecular detection of lung, prostate and head and neck cancers 2000-2002. She was clinical lead for Public Health England’s National Disease Registry (Radiotherapy Dataset) 2017-2019 and the UK National Lung Cancer Audit and the UK National Mesothelioma Audit from 2016-2020. She was a clinical oncology examiner for the UK Royal College of Radiologists 2017-2019.
Her current research interests are translational and radiotherapy trials for lung cancer, stereotactic ablative body radiotherapy (SABR), combined modality therapy and utilising national quality cancer registry datasets to highlight and address variation in clinical outcome. She is a current member of the Trans Tasman Radiation Oncology Group (TROG), Thoracic Oncology Group Australia (TOGA), International Mesothelioma Interest Group (iMig), International Thymic Malignancy Interest Group (ITMIG), American Society for Radiation Oncology (ASTRO) and International Association for the Study of Lung Cancer (IASLC).
- British Medical Journal Cancer Care Team of the Year Award 2014 (Mesothelioma team)
- Cambridge Divisional Excellence Award for Cancer (SABR Service Lead) 2013
- SIOP Travel Scholarship for AACR/ESTRO Methods in Clinical Cancer Research Workshop 2004
- AACR Outstanding Clinical Scholar-in-Training Award 2003